Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	The Medical Article of the Year 2008

Hepatitis

Free Subscription Articles published in Vaccine Retrieve available abstracts of 84 articles: HTML format

Single Articles

June 2008
1. PARK SH , Lee SR, Hyun BH, Kim BM, et al
   Codelivery of PEG-IFN-alpha inhibits HCV DNA vaccine-induced T cell responses but not humoral responses in African green monkeys.
   Vaccine. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
2. LUXEMBOURG A , Hannaman D, Wills K, Bernard R, et al
   Immunogenicity in mice and rabbits of DNA vaccines expressing woodchuck hepatitis virus antigens.
   Vaccine. 2008;.
   PubMed     Related articles    Abstract available
   
   
   May 2008
3. DUTTA T , Garg M, Jain NK
   Poly(propyleneimine) dendrimer and dendrosome mediated genetic immunization against hepatitis B.
   Vaccine. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
4. LIN HH , Liao HW, Lin SK, Wang LY, et al
   HLA and response to booster hepatitis B vaccination in anti-HBs-seronegative adolescents who had received primary infantile vaccination.
   Vaccine. 2008;.
   PubMed     Related articles    Abstract available
   
   
   April 2008
5. SAADE F , Buronfosse T, Pradat P, Abdul F, et al
   Enhancement of neutralizing humoral response of DNA vaccine against duck hepatitis B virus envelope protein by co-delivery of cytokine genes.
   Vaccine. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
6. XING Y , Huang Z, Lin Y, Li J, et al
   The ability of Hepatitis B surface antigen DNA vaccine to elicit cell-mediated immune responses, but not antibody responses, was affected by the deglysosylation of S antigen.
   Vaccine. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
7. ROSIC I , Malicevic S, Medic S, Vlasich C, et al
   Immune response by athletes to hepatitis B vaccination.
   Vaccine. 2008;.
   PubMed     Related articles   
   
   
   
8. LIANG A , Cao S, Han L, Yao Y, et al
   Construction and evaluation of the eukaryotic expression plasmid encoding two copies of somatostatin genes fused with hepatitis B surface antigen gene S.
   Vaccine. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
9. CHUA BY , Eriksson EM, Brown LE, Zeng W, et al
   A self-adjuvanting lipopeptide-based vaccine candidate for the treatment of hepatitis C virus infection.
   Vaccine. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
10. MUTWIRI G , Benjamin P, Soita H, Babiuk LA, et al
    Co-administration of polyphosphazenes with CpG oligodeoxynucleotides strongly enhances immune responses in mice immunized with Hepatitis B virus surface antigen.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
11. MARTIN P , Simon B, Lone YC, Chatel L, et al
    A vector-based minigene vaccine approach results in strong induction of T-cell responses specific of hepatitis C virus.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
12. BATDELGER D , Dandii D, Jirathitikal V, Bourinbaiar AS, et al
    Open-label trial of therapeutic immunization with oral V-5 Immunitor (V5) vaccine in patients with chronic hepatitis C.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    March 2008
13. EKRA D , Herbinger KH, Konate S, Leblond A, et al
    A non-randomized vaccine effectiveness trial of accelerated infant hepatitis B immunization schedules with a first dose at birth or age 6 weeks in Cote d'Ivoire.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
14. AJELLI M , Iannelli M, Manfredi P, degli Atti ML, et al
    Basic mathematical models for the temporal dynamics of HAV in medium-endemicity Italian areas.
    Vaccine. 2008;26:1697-707.
    PubMed     Related articles    Abstract available
    
    
    
15. POHLSCHEIDT M , Langer U, Minuth T, Bodeker B, et al
    Development and optimisation of a procedure for the production of Parapoxvirus ovis by large-scale microcarrier cell culture in a non-animal, non-human and non-plant-derived medium.
    Vaccine. 2008;26:1552-65.
    PubMed     Related articles    Abstract available
    
    
    February 2008
16. SKRASTINA D , Bulavaite A, Sominskaya I, Kovalevska L, et al
    High immunogenicity of a hydrophilic component of the hepatitis B virus preS1 sequence exposed on the surface of three virus-like particle carriers.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
17. DOMINGUEZ A , Oviedo M, Carmona G, Batalla J, et al
    Impact and effectiveness of a mass hepatitis A vaccination programme of preadolescents seven years after introduction.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
18. DIAZ-MITOMA F , Law B, Subramanya A, Hoet B, et al
    Long-term antibody persistence induced by a combined hepatitis A and B vaccine in children and adolescents.
    Vaccine. 2008;26:1759-1763.
    PubMed     Related articles    Abstract available
    
    
    January 2008
19. MURAKAMI H , Van Cuong N, Huynh L, Hipgrave DB, et al
    Implementation of and costs associated with providing a birth-dose of hepatitis B vaccine in Viet Nam.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
20. KARABAY O , Temel A, Koker AG, Tokel M, et al
    Influence of circadian rhythm on the efficacy of the hepatitis B vaccination.
    Vaccine. 2008;.
    PubMed     Related articles   
    
    
    
21. VANDEPAPELIERE P , Horsmans Y, Moris P, Van Mechelen M, et al
    Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
22. JAFARZADEH A , Zarei S, Shokri F
    Low dose revaccination induces robust protective anti-HBs antibody response in the majority of healthy non-responder neonates.
    Vaccine. 2008;26:269-76.
    PubMed     Related articles    Abstract available
    
    
    
23. FERNANDES SJ , Slhessarenko N, Souto FJ
    Effects of vertical HIV infection on the persistence of anti-HBs after a schedule of three doses of recombinant hepatitis B vaccine.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    December 2007
24. KOTWAL GJ
    Genetic diversity-independent neutralization of pandemic viruses (e.g. HIV), potentially pandemic (e.g. H5N1 strain of influenza) and carcinogenic (e.g. HBV and HCV) viruses and possible agents of bioterrorism (variola) by enveloped virus neutralizing co
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
25. CARNIEL EF , Morcillo AM, Blotta MH, Da Silva MT, et al
    Immunogenicity and safety of combined intradermal recombinant Hepatitis B with BCG vaccines at birth.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
26. WHEELER CM , Bautista OM, Tomassini JE, Nelson M, et al
    Safety and immunogenicity of co-administered quadrivalent human papillomavirus (HPV)-6/11/16/18 L1 virus-like particle (VLP) and hepatitis B (HBV) vaccines.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    November 2007
27. SELNIKOVA O , Moisseeva A, Zadorozhnaja V, Dokachenko A, et al
    Hepatitis A vaccination effectiveness during an outbreak in the Ukraine.
    Vaccine. 2007;.
    PubMed     Related articles   
    
    
    
28. JIANG WP , Chen JT, Wang X, Wang YL, et al
    Immunogenicity and safety of three consecutive lots of a new preservative-free inactivated hepatitis A vaccine (Healive((R))): A double-blind, randomized and controlled trial.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
29. LORENT E , Bierau H, Engelborghs Y, Verheyden G, et al
    Structural characterisation of the hepatitis C envelope glycoprotein E1 ectodomain derived from a mammalian and a yeast expression system.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
30. SALLERAS L , Dominguez A, Bruguera M, Plans P, et al
    Declining prevalence of hepatitis B virus infection in Catalonia (Spain) 12 years after the introduction of universal vaccination.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
31. MOHLER-KUO M , Steffen R, Bopp M, Jacobs RJ, et al
    Prevalence of hepatitis A virus risk factors in a very low endemic country, Switzerland.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    October 2007
32. LIN CC , Chang CK, Huang YL, Tseng HF, et al
    Low seroprevalence of hepatitis B surface antibody among nursing students in Taiwan: An implication for boosting.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
33. VANDEPAPELIERE P , Lau GK, Leroux-Roels G, Horsmans Y, et al
    Therapeutic vaccination of chronic hepatitis B patients with virus suppression by antiviral therapy: A randomized, controlled study of co-administration of HBsAg/AS02 candidate vaccine and lamivudine.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
34. BAUCH CT , Anonychuk AM, Pham BZ, Gilca V, et al
    Cost-utility of universal hepatitis A vaccination in Canada.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
35. FITZSIMONS D , Vorsters A, Hoppenbrouwers K, Van Damme P, et al
    Prevention and control of viral hepatitis through adolescent health programmes in Europe.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
36. BORKAKOTY B , Mahanta J, Biswas D
    HBV vaccination in hyperendemic remote tribal areas in India.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    September 2007
37. SU FH , Cheng SH, Li CY, Chen JD, et al
    Hepatitis B seroprevalence and anamnestic response amongst Taiwanese young adults with full vaccination in infancy, 20 years subsequent to national hepatitis B vaccination.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
38. STAMATAKI Z , Coates S, Evans MJ, Wininger M, et al
    Hepatitis C virus envelope glycoprotein immunization of rodents elicits cross-reactive neutralizing antibodies.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
39. SERRANO B , Bayas JM, Bruni L, Diez C, et al
    Solid organ transplantation and response to vaccination.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
40. SABIDO M , Gavalda L, Olona N, Ramon JM, et al
    Timing of hepatitis B vaccination: Its effect on vaccine response in health care workers.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
41. STOJANOV S , Liese JG, Belohradsky BH, Vandermeulen C, et al
    Administration of hepatitis A vaccine at 6 and 12 months of age concomitantly with hexavalent (DTaP-IPV-PRP approximately T-HBs) combination vaccine.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    August 2007
42. FOURNILLIER A , Gerossier E, Evlashev A, Schmitt D, et al
    An accelerated vaccine schedule with a poly-antigenic hepatitis C virus MVA-based candidate vaccine induces potent, long lasting and in vivo cross-reactive T cell responses.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
43. YUTANI S , Yamada A, Yoshida K, Takao Y, et al
    Phase I clinical study of a personalized peptide vaccination for patients infected with hepatitis C virus (HCV) 1b who failed to respond to interferon-based therapy.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
44. LIU CY , Chang NT, Chou P
    Seroprevalence of HBV in immigrant pregnant women and coverage of HBIG vaccine for neonates born to chronically infected immigrant mothers in Hsin-Chu County, Taiwan.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
45. LATIMER WW , Moleko AG, Melnikov A, Mitchell M, et al
    Prevalence and correlates of hepatitis A among adult drug users: The significance of incarceration and race/ethnicity.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
46. GIDDING HF , Warlow M, Macintyre CR, Backhouse J, et al
    The impact of a new universal infant and school-based adolescent hepatitis B vaccination program in Australia.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
47. WANG LY , Lin HH
    Short-term response to a booster dose of hepatitis B vaccine in anti-HBs negative adolescents who had received primary vaccination 16 years ago.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    July 2007
48. LIU M , Chen H, Luo F, Li P, et al
    Deletion of N-glycosylation sites of hepatitis C virus envelope protein E1 enhances specific cellular and humoral immune responses.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
49. HAMMITT LL , Hennessy TW, Fiore AE, Zanis C, et al
    Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: A follow-up study at 15 years.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
50. MISHRA D , Mishra PK, Dubey V, Dabadghao S, et al
    Evaluation of uptake and generation of immune response by murine dendritic cells pulsed with hepatitis B surface antigen-loaded elastic liposomes.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    June 2007
51. LOUTAN L , Bovier P, Herzog C
    Immunogenicity and safety of a virosomal hepatitis A vaccine in HIV-positive patients.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
52. SCHLAPHOFF V , Klade CS, Jilma B, Jelovcan SB, et al
    Functional and phenotypic characterization of peptide-vaccine-induced HCV-specific CD8+ T cells in healthy individuals and chronic hepatitis C patients.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
53. HUANG ML , Liao WL, Ho MS
    HBV serological markers of vaccinated children in remote areas of Taiwan: Emphasis on factors contributing to vaccine failure.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
54. CREATI M , Saleh A, Ruff TA, Stewart T, et al
    Implementing the birth dose of hepatitis B vaccine in rural Indonesia.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
55. HOCINE MN , Farrington CP, Touze E, Whitaker HJ, et al
    Hepatitis B vaccination and first central nervous system demyelinating events: Reanalysis of a case-control study using the self-controlled case series method.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
56. LAO-ARAYA M , Puthanakit T, Aurpibul L, Sirisanthana T, et al
    Antibody response to hepatitis B re-vaccination in HIV-infected children with immune recovery on highly active antiretroviral therapy.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    May 2007
57. D'UGO E , Kondili LA, Canitano A, Catone S, et al
    Rapid emergence of a viral resistant mutant in WHV chronically infected woodchucks treated with lamivudine and a pre-S/S CHO-derived hepatitis B virus vaccine.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    April 2007
58. HASSAN S , Ziba F
    Antibody titer in Iranian children 6 years after hepatitis B vaccine administration.
    Vaccine. 2007;25:3511-4.
    PubMed     Related articles    Abstract available
    
    
    
59. DESHMUKH TM , Lole KS, Tripathy AS, Arankalle VA, et al
    Immunogenicity of candidate hepatitis E virus DNA vaccine expressing complete and truncated ORF2 in mice.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    March 2007
60. YANG BF , Zhao HL, Xue C, Xiong XH, et al
    Recombinant heat shock protein 65 carrying hepatitis B core antigen induces HBcAg-specific CTL response.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    January 2007
61. ZHOU F , Shefer A, Weinbaum C, McCauley M, et al
    Impact of hepatitis A vaccination on health care utilization in the United States, 1996-2004.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
62. WILSON JN , Nokes DJ, Medley GF, Shouval D, et al
    Mathematical model of the antibody response to hepatitis B vaccines: Implications for reduced schedules.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
63. DA VILLA G , Romano L, Sepe A, Iorio R, et al
    Impact of hepatitis B vaccination in a highly endemic area of south Italy and long-term duration of anti-HBs antibody in two cohorts of vaccinated individuals.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
64. GABBUTI A , Romano L, Blanc P, Meacci F, et al
    Long-term immunogenicity of hepatitis B vaccination in a cohort of Italian healthy adolescents.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
65. JACKSON Y , Chappuis F, Mezger N, Kanappa K, et al
    High immunogenicity of delayed third dose of hepatitis B vaccine in travellers.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    December 2006
66. HERON L , Selnikova O, Moiseieva A, Van Damme P, et al
    Immunogenicity, reactogenicity and safety of two-dose versus three-dose (standard care) hepatitis B immunisation of healthy adolescents aged 11-15 years: A randomised controlled trial.
    Vaccine. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
67. GRUENER NH , Gerlach TJ, Ulsenheimer A, Diepolder HM, et al
    Characterization of sequence variations in immunodominant regions of the HBV-nucleocapsid protein as a prerequisite for the development of an epitope-based vaccine.
    Vaccine. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
68. YU H , Babiuk LA, van Drunen Littel-van den Hurk S
    Immunity and protection by adoptive transfer of dendritic cells transfected with hepatitis C NS3/4A mRNA.
    Vaccine. 2006;.
    PubMed     Related articles    Abstract available
    
    
    November 2006
69. BAUCH CT , Rao AS, Pham BZ, Krahn M, et al
    A dynamic model for assessing universal Hepatitis A vaccination in Canada.
    Vaccine. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
70. YAO X , Zheng B, Zhou J, Xu DZ, et al
    Therapeutic effect of hepatitis B surface antigen-antibody complex is associated with cytolytic and non-cytolytic immune responses in hepatitis B patients.
    Vaccine. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
71. PARTRIDGE S , Alvey J, Bernstein H, Blatter M, et al
    Safety of a combination diphtheria, tetanus toxoid, acellular pertussis, hepatitis B, and inactivated polio vaccine coadministered with a 7-valent pneumococcal conjugate vaccine and a Haemophilus influenzae type b conjugate vaccine.
    Vaccine. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
72. DONG C , Dai X, Meng JH
    The first experimental study on a candidate combined vaccine against hepatitis A and hepatitis E.
    Vaccine. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
73. HALLER AA , Lauer GM, King TH, Kemmler C, et al
    Whole recombinant yeast-based immunotherapy induces potent T cell responses targeting HCV NS3 and Core proteins.
    Vaccine. 2006;.
    PubMed     Related articles    Abstract available
    
    
    October 2006
74. OBARO SK , Ota MO
    Sense and the science of childhood immunization: can we achieve more with less?
    Vaccine. 2006;24.
    PubMed     Related articles    Abstract available
    
    
    
75. VAN DER SANDE MA , Mendy M, Waight P, Doherty C, et al
    Similar long-term vaccine efficacy of two versus three doses of HBV vaccine in early life.
    Vaccine. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
76. HOHLER T , Groeger-Bicanic G, Hoet B, Stoffel M, et al
    Antibody persistence and immune memory elicited by combined hepatitis A and B vaccination in older adults.
    Vaccine. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
77. LI P , Wan Q, Feng Y, Liu M, et al
    Engineering of N-glycosylation of hepatitis C virus envelope protein E2 enhances T cell responses for DNA immunization.
    Vaccine. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
78. WOUTERS K , Leuridan E, Van Herck K, Van Ardenne N, et al
    Compliance and immunogenicity of two hepatitis B vaccination schedules in sex workers in Belgium.
    Vaccine. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
79. HEININGER U , Sanger R, Jacquet JM, Schuerman L, et al
    Booster immunization with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate combination vaccine in the second year of life: Safety, immunogenicity and persist
    Vaccine. 2006;.
    PubMed     Related articles    Abstract available
    
    
    September 2006
80. GUO H , Zhou EM, Sun ZF, Meng XJ, et al
    Protection of chickens against avian hepatitis E virus (avian HEV) infection by immunization with recombinant avian HEV capsid protein.
    Vaccine. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
81. RENDI-WAGNER P , Korinek M, Winkler B, Kundi M, et al
    Persistence of seroprotection 10 years after primary hepatitis A vaccination in an unselected study population.
    Vaccine. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
82. BRAKA F , Nanyunja M, Makumbi I, Mbabazi W, et al
    Hepatitis B infection among health workers in Uganda: Evidence of the need for health worker protection.
    Vaccine. 2006;.
    PubMed     Related articles    Abstract available
    
    
    July 2006
83. WALLACE DB , Ellis CE, Espach A, Smith SJ, et al
    Protective immune responses induced by different recombinant vaccine regimes to Rift Valley fever.
    Vaccine. 2006;.
    PubMed     Related articles    Abstract available
    
    
    June 2006
84. LEWIS RF , Braka F, Mbabazi W, Makumbi I, et al
    Exposure of Ugandan health personnel to measles and rubella: Evidence of the need for health worker vaccination.
    Vaccine. 2006;.
    PubMed     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: